Publication Name	World Journal of Clinical Urology
Manuscript ID	11363
Country	Israel

Received	2014-05-18 16:45
Peer-Review Started	2014-05-18 23:14
To Make the First Decision	2014-06-27 12:02
Return for Revision	2014-07-04 12:24
Revised	2014-07-27 23:28
Second Decision	2014-11-14 09:42
Accepted by Journal Editor-in-Chief	2014-11-26 22:13
Accepted by Company Editor-in-Chief	2014-11-19 10:51
Articles in Press	2014-11-19 10:51
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-03-19 16:00
Publish the Manuscript Online	2015-03-25 08:34

ISSN	2219-2816 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Urology & Nephrology
Manuscript Type	Observational Study
Article Title	Role of PCA3 test in clinical decision making for prostate cancer diagnosis
Manuscript Source	Invited Manuscript
All Author List	Vladimir Yutkin, Ali Al-Zahrani, Andrew Williams, Guy Hidas, Carlos Martinez, Jonathan Izawa, Dov Pode and Joseph Chin
Funding Agency and Grant Number
Corresponding Author	Dr. Vladimir Yutkin, Urology Department, Hadassah and Hebrew University Medical Center, Ein Kerem Campus, POB 12000, Jerusalem 91120, Israel. yutkin@hadassah.org.il
Key Words	Prostate cancer; Prostate biopsy; Prostate specific antigen; PCA3; Decision making
Core Tip	PCA3 is a molecular urine test, which is performed in patients with high risk for prostate cancer. In this international prospective study we demonstrate that it has better performance than routine serum prostate specific antigen test in men with previously negative prostate biopsies. We also show that patients and physicians tend to follow the recommendations for this test.
Publish Date	2015-03-25 08:34
Citation	Yutkin V, Al-Zahrani A, Williams A, Hidas G, Martinez C, Izawa J, Pode D, Chin J. Role of PCA3 test in clinical decision making for prostate cancer diagnosis. World J Clin Urol 2015; 4(1): 68-74
URL	http://www.wjgnet.com/2219-2816/full/v4/i1/68.htm
DOI	http://dx.doi.org/10.5410/wjcu.v4.i1.68

Full Article (PDF)	WJCU-4-68.pdf
Full Article (Word)	WJCU-4-68.doc
Manuscript File	11363-Review.docx
Answering Reviewers	11363-Answering reviewers.pdf
Copyright License Agreement	11363-Copyright assignment.pdf
Peer-review Report	11363-Peer review(s).pdf
Scientific Misconduct Check	11363-CrossCheck.jpg
Scientific Editor Work List	11363-Scientific editor work list.pdf